Pre-operative Inspiratory Muscle Training Program to Prevent Pulmonary Complications After Thoracic Surgery
CT0076
1 other identifier
interventional
141
1 country
1
Brief Summary
Postoperative pulmonary complications are the most common complications after thoracic surgery. In the literature, pulmonary complications after thoracic surgery are present in more than 37.5% of patients. No study investigates the impact of preoperative inspiratory muscle exercises program on pulmonary complications after thoracic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable lung-cancer
Started Jan 2019
Typical duration for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2018
CompletedFirst Posted
Study publicly available on registry
November 20, 2018
CompletedStudy Start
First participant enrolled
January 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2022
CompletedFebruary 15, 2023
February 1, 2023
1.8 years
September 13, 2018
February 14, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Numbers of postoperative pulmonary complications
Up to 30 days after surgery
Secondary Outcomes (2)
Numbers of morbidity and mortality
Up to 30 days after surgery
Length of stay (by days)
Up to 30 days after surgery
Study Arms (2)
inspiratory muscle program
EXPERIMENTALInspiratory muscle training preoperative with standard of care
no inspiratory muscle program
OTHERstandard of care: postoperative spirometry with enhanced recovery program in thoracic surgery
Interventions
pre-operative inspiratory muscular training program
Eligibility Criteria
You may qualify if:
- Able to consent
- Pulmonary resection: segmental resection or lobectomy or bilobectomy
- With or without previous pulmonary resection
- Thoracotomy and minimally invasive surgery
- With or without neoadjuvant chemotherapy
- or more risk factors for pulmonary complications (over 70 years, cough and sputum, diabetes, smoking, FEV1 less than 75% or under pump, BMI over 27 kg / m2, FEV1 less than 80%, TIFF less than 70%, NYHA II or sleep apnea)
You may not qualify if:
- Refusal of the patient
- Pregnancy
- Pneumonectomy
- FEV1 less than 30%
- DLCO less than 30%
- Vo2 MAX less than 10cc / min / kg
- Contraindication to respiratory physiotherapy - Myocardial infarction or cerebrovascular accident for less than 1 year, unstable angina, aneurysm, significant hemoptysis less than 90 days, muscular or neurological pathology constraining respiratory physiotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHUM
Montreal, Quebec, H2X3E4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Moishe Liberman, MD, PhD
CHUM
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2018
First Posted
November 20, 2018
Study Start
January 7, 2019
Primary Completion
October 31, 2020
Study Completion
October 31, 2022
Last Updated
February 15, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share